Posts by: Maureen Newman

Maureen Newman

Maureen Newman is a science columnist for Pulmonary Hypertension News. She is currently a PhD student studying biomedical engineering at University of Rochester, working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit's laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment.

September 16, 2014November 6, 2015

Progress in Superior Treatments for Superbugs Could Impact Pneumonia, Bronchiectasis & Cystic Fibrosis Patients

Bronchiectasis, Cystic Fibrosis, News

A team of researchers from the Agency for Science, Technology and Research’s (A*STAR) Institute of Chemical and Engineering Sciences (ICES) and the National University Hospital (NUH) is working toward returning ... Read more

September 5, 2014November 11, 2015

Nearly Half of Studied COPD Patients Suffer Breathlessness

COPD, News

Shortness of breath, otherwise known as dyspnoea or “air hunger,” is a common symptom of chronic obstructive pulmonary disease (COPD). It is a serious problem that should not be ignored, ... Read more

August 21, 2014November 5, 2015

Mucus Strands May Trap Particles in the Lungs of Cystic Fibrosis Patients

Cystic Fibrosis, News

While for the majority of individuals mucus is just a substance in the lungs made to clear bacteria, viruses, and foreign particles out of the lungs, for patients with cystic ... Read more

August 20, 2014November 11, 2015

Tiotropium Respimat Recommended for FDA Approval to Treat COPD

COPD, News

In a 10-to-3 vote by the Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee (FDA PADAC), Boehringer Ingelheim Pharmaceuticals, Inc.’s investigational nasal spray tiotropium bromide has been recommended for approval ... Read more

August 1, 2014November 6, 2015

Drug from Genetech Under Evaluation to Treat Severe Asthma

Asthma, News

Scientists at McMaster University in Ontario and colleagues in California, Sweden, and other provinces of Canada are formulating a therapy with a different perspective on treating asthma. If the new ... Read more

July 7, 2014November 5, 2015

Cystic Fibrosis Lung Transplant Patient First in US to be Saved by Hemolung

Cystic Fibrosis

When Jon Sacker, a 33-year-old cystic fibrosis patient from Moore, Oklahoma, was too sick for a lifesaving double lung transplant, clinicians at University of Pittsburgh Medical Center decided he was going to ... Read more

June 23, 2014November 11, 2015

COPD Foundation Finds Many COPD Patients Are Unaware of Managing Their Condition

COPD

Nearly two-thirds (62%) of patients with chronic obstructive pulmonary disease (COPD) know very little about exacerbations (flare-ups of symptoms), and 16% do not know what exacerbations are. Healthcare providers are ... Read more

June 20, 2014November 6, 2015

Asmacure’s ASM-024 Safe and Tolerated During Phase 1/2a Clinical Trial

Asthma, News

Clinical-stage biopharmaceutical company Asmacure has new results from its Phase 1/2a clinical trial evaluating its lead product in moderate asthma patients. Results show ASM-024, a novel compound that targets cholinergic ... Read more

June 17, 2014November 11, 2015

Tiotropium Improves Survival in High-Risk COPD Patients

COPD, News

A team of international collaborators from France, Germany, Belgium, and the United States (University of North Carolina at Chapel Hill and Boehringer Ingelheim Pharma GmbH & Co KG) found benefits ... Read more

June 11, 2014November 11, 2015

Invion Formulates Nadolol to Aid in Smoking Cessation

Chronic Bronchitis, COPD

Invion, Inc. is currently enrolling 136 patients with chronic obstructive pulmonary disease (COPD) for a Phase 2 clinical trial evaluating its drug INV102 (nadolol). The goal of the study is ... Read more